219 related articles for article (PubMed ID: 11156546)
21. Rheumatoid factors, anti-filaggrin antibodies and low in vitro interleukin-2 and interferon-gamma production are useful immunological markers for early diagnosis of community cases of rheumatoid arthritis. A preliminary study.
Vittecoq O; Jouen-Beades F; Krzanowska K; Bichon-Tauvel I; Ménard JF; Daragon A; Tron F; Le Loët X
Joint Bone Spine; 2001 Mar; 68(2):144-53. PubMed ID: 11324930
[TBL] [Abstract][Full Text] [Related]
22. Induction of proliferation and pro-inflammatory cytokine production in rheumatoid arthritis peripheral blood mononuclear cells by a 65 KDa chondrocyte membrane-specific, constitutive target autoantigen (CH65).
Alsalameh RJ; Casey RC; Mollenhauer J; Kalden JR; Burmester GR; Alsalameh SM
Int J Rheum Dis; 2017 Sep; 20(9):1132-1141. PubMed ID: 24131486
[TBL] [Abstract][Full Text] [Related]
23. Immune complexes from rheumatoid arthritis synovial fluid induce FcgammaRIIa dependent and rheumatoid factor correlated production of tumour necrosis factor-alpha by peripheral blood mononuclear cells.
Mathsson L; Lampa J; Mullazehi M; Rönnelid J
Arthritis Res Ther; 2006; 8(3):R64. PubMed ID: 16569263
[TBL] [Abstract][Full Text] [Related]
24. T cell epitopes of type II collagen in HLA-DRB1*0101 or DRB1*0405-positive Japanese patients with rheumatoid arthritis.
Ohnishi Y; Tsutsumi A; Sakamaki T; Sumida T
Int J Mol Med; 2003 Mar; 11(3):331-5. PubMed ID: 12579335
[TBL] [Abstract][Full Text] [Related]
25. Evidence that rheumatoid arthritis synovial T cells are similar to cytokine-activated T cells: involvement of phosphatidylinositol 3-kinase and nuclear factor kappaB pathways in tumor necrosis factor alpha production in rheumatoid arthritis.
Brennan FM; Hayes AL; Ciesielski CJ; Green P; Foxwell BM; Feldmann M
Arthritis Rheum; 2002 Jan; 46(1):31-41. PubMed ID: 11822409
[TBL] [Abstract][Full Text] [Related]
26. Anti-type II collagen immune complex-induced granulocyte reactivity is associated with joint erosions in RA patients with anti-collagen antibodies.
Manivel VA; Sohrabian A; Wick MC; Mullazehi M; Håkansson LD; Rönnelid J
Arthritis Res Ther; 2015 Jan; 17(1):8. PubMed ID: 25598326
[TBL] [Abstract][Full Text] [Related]
27. Role of placenta growth factor and its receptor flt-1 in rheumatoid inflammation: a link between angiogenesis and inflammation.
Yoo SA; Yoon HJ; Kim HS; Chae CB; De Falco S; Cho CS; Kim WU
Arthritis Rheum; 2009 Feb; 60(2):345-54. PubMed ID: 19180491
[TBL] [Abstract][Full Text] [Related]
28. Biphasic emergence of active tuberculosis in rheumatoid arthritis patients receiving TNFα inhibitors: the utility of IFNγ assay.
Chen DY; Shen GH; Chen YM; Chen HH; Hsieh CW; Lan JL
Ann Rheum Dis; 2012 Feb; 71(2):231-7. PubMed ID: 22021896
[TBL] [Abstract][Full Text] [Related]
29. Multifunctional T cell reactivity with native and glycosylated type II collagen in rheumatoid arthritis.
Snir O; Bäcklund J; Boström J; Andersson I; Kihlberg J; Buckner JH; Klareskog L; Holmdahl R; Malmström V
Arthritis Rheum; 2012 Aug; 64(8):2482-8. PubMed ID: 22392632
[TBL] [Abstract][Full Text] [Related]
30. Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis.
Zheng ZH; Li XY; Ding J; Jia JF; Zhu P
Rheumatology (Oxford); 2008 Jan; 47(1):22-30. PubMed ID: 18077486
[TBL] [Abstract][Full Text] [Related]
31. [1,25(OH)2-Vitamin-D3 attenuates Th17-related cytokines expression in peripheral blood mononuclear cells in patients with early-diagnosed rheumatoid arthritis].
Wen H; Luo J; Zhang X; Zhang C; Zhao X; Wang X; Li X
Zhonghua Nei Ke Za Zhi; 2015 Apr; 54(4):317-21. PubMed ID: 26268060
[TBL] [Abstract][Full Text] [Related]
32. Low T cell production of TNFalpha and IFNgamma in ankylosing spondylitis: its relation to HLA-B27 and influence of the TNF-308 gene polymorphism.
Rudwaleit M; Siegert S; Yin Z; Eick J; Thiel A; Radbruch A; Sieper J; Braun J
Ann Rheum Dis; 2001 Jan; 60(1):36-42. PubMed ID: 11114280
[TBL] [Abstract][Full Text] [Related]
33. Enhanced in vitro induced production of interleukin 10 by peripheral blood mononuclear cells in rheumatoid arthritis is associated with clinical response to methotrexate treatment.
Seitz M; Zwicker M; Wider B
J Rheumatol; 2001 Mar; 28(3):496-501. PubMed ID: 11296948
[TBL] [Abstract][Full Text] [Related]
34. Ex vivo inhibited cytokine profiling may explain inferior treatment response to golimumab after adalimumab failure in rheumatoid arthritis.
Tweehuysen L; Schraa K; Netea MG; van den Hoogen FHJ; Joosten LAB; den Broeder AA
Clin Exp Rheumatol; 2018; 36(1):140-143. PubMed ID: 29148425
[TBL] [Abstract][Full Text] [Related]
35. Macrophage migration inhibitory factor in rheumatoid arthritis: evidence of proinflammatory function and regulation by glucocorticoids.
Leech M; Metz C; Hall P; Hutchinson P; Gianis K; Smith M; Weedon H; Holdsworth SR; Bucala R; Morand EF
Arthritis Rheum; 1999 Aug; 42(8):1601-8. PubMed ID: 10446857
[TBL] [Abstract][Full Text] [Related]
36. Tumor necrosis factor-alpha blockade leads to decreased peripheral T cell reactivity and increased dendritic cell number in peripheral blood of patients with ankylosing spondylitis.
Pang L; Wang L; Suo T; Hao H; Fang X; Jia J; Huang F; Tang J
J Rheumatol; 2008 Nov; 35(11):2220-8. PubMed ID: 19004053
[TBL] [Abstract][Full Text] [Related]
37. [T cell proliferative response and antibody formation to citrullinated collagen type II in patients with rheumatoid arthritis].
Tian X; Zhao Y; Li ZG
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(10):673-6. PubMed ID: 19595060
[TBL] [Abstract][Full Text] [Related]
38. Interleukin-18 enhances monocyte tumor necrosis factor alpha and interleukin-1beta production induced by direct contact with T lymphocytes: implications in rheumatoid arthritis.
Dai SM; Matsuno H; Nakamura H; Nishioka K; Yudoh K
Arthritis Rheum; 2004 Feb; 50(2):432-43. PubMed ID: 14872485
[TBL] [Abstract][Full Text] [Related]
39. Tumour necrosis factor (TNF) production by T cell receptor-primed T lymphocytes is a target for low dose methotrexate in rheumatoid arthritis.
Hildner K; Finotto S; Becker C; Schlaak J; Schirmacher P; Galle PR; Märker-Hermann E; Neurath MF
Clin Exp Immunol; 1999 Oct; 118(1):137-46. PubMed ID: 10540171
[TBL] [Abstract][Full Text] [Related]
40. Addition of interleukin 1 (IL1) and IL17 soluble receptors to a tumour necrosis factor alpha soluble receptor more effectively reduces the production of IL6 and macrophage inhibitory protein-3alpha and increases that of collagen in an in vitro model of rheumatoid synoviocyte activation.
Chevrel G; Garnero P; Miossec P
Ann Rheum Dis; 2002 Aug; 61(8):730-3. PubMed ID: 12117682
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
